GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » General and Admin. Expense

InventisBio Co (SHSE:688382) General and Admin. Expense : ¥33.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. InventisBio Co's General and Admin. Expense for the three months ended in Mar. 2025 was ¥10.4 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥33.2 Mil.

InventisBio Co General and Admin. Expense Historical Data

The historical data trend for InventisBio Co's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co General and Admin. Expense Chart

InventisBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
General and Admin. Expense
Get a 7-Day Free Trial 13.17 34.09 37.82 41.91 33.44

InventisBio Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.65 4.71 27.83 -9.74 10.41

InventisBio Co General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥33.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InventisBio Co General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of InventisBio Co's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InventisBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » General and Admin. Expense
Comparable Companies
SZSE:300294 SZSE:300009 SZSE:002287 SHSE:600866 SZSE:000403 SHSE:688076 SHSE:688068 SHSE:688739 SHSE:688520 SHSE:600645 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
Website
http://www.inventisbio.com
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines